i-have-been-tracking-jubilant-ingrevia-since-rakesh-jhunjhunwala-holds-this-stock-and-want-to-know-its-prospects-after-the-quarterly-results-for-march-2022-
why-was-jubilant-pharma-seeing-so-much-of-positive-action-on-19-april-
what-explains-the-sharp-fall-in-net-profits-of-jubilant-life-sciences-in-the-jun-20-quarter-
how-is-jubilant-s-covid-drug-priced-in-the-market-
what-could-be-the-impact-of-jubilant-life-getting-dcgi-approval-for-its-remdesivir-version-
how-will-bharat-biotech-manage-to-launch-the-covid-vaccine-by-august-15--which-is-the-deadline-given-by-icmr-
is-it-true-that-india-has-managed-to-develop-its-first-indigenous-vaccine-for-covid-19-and-when-it-is-likely-to-hit-markets-
what-is-the-significance-of-hetero-drugs-getting-domestic-approval-for-remdesivir-
what-is-the-difference-between-the-covid-19-permissions-that-glenmark-has-got-compared-to-what-cipla-and-jubilant-have-received-
can-i-buy-jubilant-life-sciences-at-the-current-price-of-rs-625--even-after-the-sharp-rally-in-recent-days-
with-gilead-seeing-some-early-success-in-covid-19-drug-testing--do-you-see-that-as-a-positive-for-cipla-and-jubilant-life-
why-are-gilead-of-uk-and-astra-zeneca-looking-at-a-pharma-merger-deal-right-now-
has-the-use-of-remdesivir-for-covid-19-been-approved-in-india-and-what-does-that-mean-for-jubilant-and-cipla-
what-will-be-the-implications-of-gilead-approval-for-cipla-and-jubilant-
is-jubilant-life-sciences-worth-buying-at-current-prices-after-the-latest-quarter-results-
can-i-buy-cipla-and-jubilant-life--now-that-they-are-allowed-to-manufacture-the-covid-19-drug-in-india-
is-it-true-that-cipla--hetero-and-jubilant-have-been-licensed-by-gilead-for-the-covid-19-manufacture-